The New Jersey health department’s referral of the Somerset incidents to the state attorney general’s office

The New Jersey health department’s referral of the Somerset incidents to the state attorney general’s office was a turning point in the response to unexplained patient harm at Somerset Medical Center. On September 26, 2003, department officials asked to pursue legal advice about a referral after discovering that the hospital had reported a fourth incident a month late, despite being told to report any further cases promptly. The decision came after an earlier attempt to refer the matter had been declined, and as officials increasingly suspected that the incidents might involve foul play.

Background and Delayed Escalation

Before the referral, Bruce Ruck and Steven Marcus of the New Jersey Poison Control Center had pressed Somerset Medical Center to acknowledge the significance of the patient incidents. Marcus believed the available data were not ambiguous and feared that delay could expose more patients to harm. Ruck repeatedly insisted that the matter belonged with police, rather than being left solely to hospital physicians or administrators. Somerset did not promptly respond to Poison Control’s requests for an update, and the institutional response remained slow.

The health department’s concerns had also developed over time. Commissioner Cliff Lacey had previously considered a referral to the Attorney General’s office but declined, reasoning that explanations other than foul play remained plausible. That earlier decision left the incidents within a less urgent frame: abnormal outcomes that might be explained medically, rather than a pattern requiring criminal investigation.

The Fourth Incident and the September 26 Decision

On September 26, senior department staff learned that Somerset had reported a fourth unexplained incident that day, although the incident itself had occurred a month earlier. The hospital had already been explicitly warned that additional patients needed to be reported. Maureen F. Miller informed Marilyn Dahl of the new disclosure, making the delay itself a central concern alongside the patient events.

Dahl met with Alison Gibson, director of Inspections, Compliance and Complaints, and Amie Thornton, assistant commissioner of Health Care Facility Quality. They agreed that there might now be sufficient reason to suspect foul play. In their assessment, Somerset’s decision to wait an entire month before reporting the fourth occurrence was irresponsible at best. They sought permission to ask the department’s Office of Legal and Regulatory Affairs for advice about referring the matter to the Attorney General’s office. The sequence matters: the referral question was prompted not only by the accumulating incidents, but by the hospital’s failure to report the latest one promptly after being warned.

From Internal Inquiry to State-Level Scrutiny

That same day, the Department of Health contacted the Attorney General’s office. The escalation followed a period in which Somerset had been investigating the incidents internally, while external officials questioned both the adequacy and the pace of that approach. The department’s move did not itself establish that a crime had occurred; it placed the possibility of foul play before state legal authorities for consideration.

The department also understood that Somerset’s own posture might have changed. Thornton reported that the hospital appeared to suspect foul play because it had retained private investigators and attorneys to investigate. Seven days later, Somerset Medical Center contacted the Somerset County Prosecutor’s Office. The referral thus forms part of a chain of increasing scrutiny: concern from Poison Control, growing alarm within the health department, contact with state legal authorities, and eventual involvement of county investigators. It exposes the cost of treating repeated unexplained patient events as an internal matter first: each delay made the question of who should act, and when, harder to separate from the underlying danger to patients.